Address	1633 Broadway New York New York 10019 United States
Employees	-
Website	http://www.delcath.com
Updated	07/08/2019
Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes Melphalan Hydrochloride for Injection, which is a proprietary product for use with the Delcath Hepatic Delivery System. The company was founded in August 1988 and is headquartered in New York, NY.